AtriCure (ATRC) Liabilities and Shareholders Equity (2010 - 2026)

AtriCure (ATRC) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $644.0 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $644.0 million, up 8.85% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.5 billion (up 5.35% YoY), and the FY2025 annual result was $654.2 million, up 7.36% from the prior year.
• Liabilities and Shareholders Equity eased to $644.0 million in Q1 2026 per ATRC's latest filing, from $654.2 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $654.2 million in Q4 2025 and troughed at $581.9 million in Q3 2022.
• A 5-year average of $604.6 million and a median of $597.3 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2026: Liabilities and Shareholders Equity decreased 16.42% in 2022, then advanced 8.85% in 2026.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $585.4 million in 2022, then advanced by 4.87% to $613.9 million in 2023, then slipped by 0.75% to $609.3 million in 2024, then advanced by 7.36% to $654.2 million in 2025, then declined by 1.56% to $644.0 million in 2026.
• Business Quant data shows ATRC's Liabilities and Shareholders Equity at $644.0 million in Q1 2026, $654.2 million in Q4 2025, and $635.4 million in Q3 2025.